198 related articles for article (PubMed ID: 7645989)
21. Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms.
Epenetos AA; Snook D; Durbin H; Johnson PM; Taylor-Papadimitriou J
Cancer Res; 1986 Jun; 46(6):3183-91. PubMed ID: 3516393
[TBL] [Abstract][Full Text] [Related]
22. Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.
Esteban JM; Colcher D; Sugarbaker P; Carrasquillo JA; Bryant G; Thor A; Reynolds JC; Larson SM; Schlom J
Int J Cancer; 1987 Jan; 39(1):50-9. PubMed ID: 3793270
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
25. Regional heterogeneity and complementation in the expression of the tumor-associated glycoprotein 72 epitopes in colorectal cancer.
Muraro R; Frati L; Bei R; Ficari F; Valli C; French D; Mammarella S; Caramia F; Fegiz G; Mariani-Costantini R
Cancer Res; 1991 Oct; 51(19):5378-83. PubMed ID: 1717150
[TBL] [Abstract][Full Text] [Related]
26. Detection of adenocarcinoma in peritoneal washings by staining with monoclonal antibody B72.3.
Szpak CA; Soper JT; Thor A; Schlom J; Johnston WW
Acta Cytol; 1989; 33(2):205-14. PubMed ID: 2648721
[TBL] [Abstract][Full Text] [Related]
27. Lymphoscintigraphy of human colorectal carcinoma metastases in athymic mice by use of radioiodinated B72.3 monoclonal antibody.
Shah SA; Gallagher BM; Sands H
J Natl Cancer Inst; 1987 Jun; 78(6):1069-77. PubMed ID: 3473248
[TBL] [Abstract][Full Text] [Related]
28. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay.
Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J
Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871
[TBL] [Abstract][Full Text] [Related]
29. Localization of tumor-reactive lymph node lymphocytes in vivo using radiolabeled monoclonal antibody.
Triozzi PL; Kim JA; Aldrich W; Young DC; Sampsel JW; Martin EW
Cancer; 1994 Feb; 73(3):580-9. PubMed ID: 8299079
[TBL] [Abstract][Full Text] [Related]
30. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
[TBL] [Abstract][Full Text] [Related]
31. Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3.
Nieroda CA; Mojzisik C; Sardi A; Farrar WB; Hinkle G; Siddiqi MA; Ferrara PJ; James A; Schlom J; Thurston MO
Surg Gynecol Obstet; 1989 Jul; 169(1):35-40. PubMed ID: 2740968
[TBL] [Abstract][Full Text] [Related]
32. A new technique for simultaneous demonstration of 4 tumor-associated antigens in pancreatic cancer cells.
Pour PM; Kazakoff K; Dulany K
Zentralbl Pathol; 1994 Nov; 140(4-5):397-401. PubMed ID: 7530041
[TBL] [Abstract][Full Text] [Related]
33. B72.3 immunoreactivity in benign abdominal lymph nodes associated with gastrointestinal disease.
Loy TS; Haege DD
Dis Colon Rectum; 1995 Sep; 38(9):983-7. PubMed ID: 7656749
[TBL] [Abstract][Full Text] [Related]
34. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
[TBL] [Abstract][Full Text] [Related]
35. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of NR-LU-10 with the Neoprobe gamma detector in a mouse model.
Lange MK; Sandhu A; Sampsel J; Hinkle G; Ignaszewski J; Martin E; Sandhu P; Martin EW
J Surg Res; 1993 Aug; 55(2):205-13. PubMed ID: 8412101
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of pre-irradiation on monoclonal antibody localization in colon tumor xenografts expressing a cell-associated antigen.
Gridley DS; Slater JB; Slater JM
Anticancer Res; 1995; 15(1):99-104. PubMed ID: 7733650
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative radioimmunolocalization of colorectal carcinoma with a hand-held gamma probe and MAb B72.3: comparison of in vivo gamma probe counts with in vitro MAb radiolocalization.
Tuttle SE; Jewell SD; Mojzisik CM; Hinkle GH; Colcher D; Schlom J; Martin EW
Int J Cancer; 1988 Sep; 42(3):352-8. PubMed ID: 3417363
[TBL] [Abstract][Full Text] [Related]
39. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.
Katari RS; Fernsten PD; Schlom J
Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
